Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Research into Oral Semaglutide and Heart Failure Outcomes
February 2026
The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.
Read more
1
Mins
5 Oct 2023
Adult Survivors of Childhood Cancer Have Significant Levels of Impaired Cardiorespiratory Fitness, Inflammatory Markers, and Poor Quality of Life Outcomes
Almost two-thirds of the 35,000 children diagnosed with cancer in Europe each year are treated with anthracycline chemotherapy. Despite…
3
Mins
5 Oct 2023
Artificial Intelligence and Heart Failure
To emphasise the importance of this topic, Oguz Akbilgic, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA…
12
Mins
5 Oct 2023
Risk Factors and Patterns of Myocardial Injury in Patients with COVID-19: A Single-Centre Cohort Study
The primary objective was to compare the risk factors and trends of patients with COVID-19 with and without biochemical evidence of…
8
Mins
5 Oct 2023
ESC 2023 Abstract Highlights
The following selected highlights showcase intriguing and relevant abstracts presented at the European Society of Cardiology (ESC)…
9
Mins
5 Oct 2023
PCSK9 Targeting in the Management of Hypercholesterolaemia
In the current era of optimal risk factor modification, proprotein convertase subtilisin/kexin type 9 (PCSK9) targeting has emerged as a…
2 Oct 2023
A New Course for HCM: ESC 2023 Highlights
Discussing the burden of hypertrophic cardiomyopathy (HCM), experts in this field shed light on the diagnosis and treatment of HCM.
29 Sep 2023
Neurologists And Cardiologists Working Together For Better Outcomes For Patients With Non-Dystrophic Myotonia
This podcast focuses on one particular treatment, mexiletine, to understand how the medication’s cardiac side-effects could affect how it is prescribed.
6
Mins
20 Sep 2023
ESC 2023 Interview: Blanche Cupido
I have worked in the public healthcare sector in South Africa since 2001, when I obtained an undergraduate degree…
Loading posts...
« Previous
1
…
39
40
41
42
43
…
96
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View